De Wildt D J, van der Beek E M, De Jong Y, Nijkamp F P, Kreeftenberg J G
Eur J Pharmacol. 1985 Jan 22;108(2):113-9. doi: 10.1016/0014-2999(85)90715-0.
Lymphocytosis promoting factor (LPF), alternatively described as pertussis toxin, inhibits the vasodilation after beta 2-adrenoceptor stimulation with salbutamol as well as the negative chronotropic activity induced by the muscarinic receptor stimulant arecoline 4 days after vaccination of rats. To analyse whether arachidonic acid metabolites contributed to these phenomena the cyclo-oxygenase inhibitor indomethacin and the phospholipase A2 inhibitor dexamethasone were administered over a period of 4 days. Pretreatment with either drug restored beta 2-adrenoceptor responsiveness. The cardiac anticholinergic effect, however, was not changed. Interestingly, neither of the inhibitors prevented the blood pressure lowering effect of LPF. The reversing effect on vascular beta 2-hyporesponsiveness of indomethacin and dexamethasone therefore appears to be rather specific. It is concluded that endogenous prostaglandins may participate in the vascular beta 2-adrenergic impairment caused by LPF. Furthermore, the results are considered in view of desensitization theories and underlying mechanisms of LPF-induced autonomic impairment.
淋巴细胞增多促进因子(LPF),也被称为百日咳毒素,在大鼠接种疫苗4天后,可抑制沙丁胺醇刺激β2-肾上腺素能受体后引起的血管舒张以及毒蕈碱受体兴奋剂槟榔碱诱导的负性变时活性。为分析花生四烯酸代谢产物是否与这些现象有关,在4天时间内给予环氧化酶抑制剂吲哚美辛和磷脂酶A2抑制剂地塞米松。用这两种药物中的任何一种进行预处理均可恢复β2-肾上腺素能受体反应性。然而,心脏抗胆碱能效应并未改变。有趣的是,这两种抑制剂均未阻止LPF的降压作用。因此,吲哚美辛和地塞米松对血管β2-低反应性的逆转作用似乎具有相当的特异性。得出的结论是,内源性前列腺素可能参与了由LPF引起的血管β2-肾上腺素能损伤。此外,从脱敏理论和LPF诱导的自主神经损伤的潜在机制的角度对结果进行了考量。